Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × lutetium Lu 177 dotatate × 90 days × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 8 Gastro-enteropancreatic neuroendocrine tumor 3 Pheochromocytoma 2 Paraganglioma 2 Meningioma 2 Adenoma, Islet Cell 2 Somatostatin Receptor-positive Neuroendocrine Tumor 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Hypertension 1 Glioblastoma 1 Extensive Stage Small Cell Lung Cancer 1 Disease Progression 1 Advanced Lung Neuroendocrine Tumor 1

Interventions

Nivolumab 8 pembrolizumab 7 avelumab 5 Specimen Handling 5 Biopsy 5 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 cemiplimab 2 atezolizumab 2 aldesleukin 2 Radiotherapy 2 Immunoglobulin G 2 Cyclophosphamide 2 Bevacizumab 2 tocilizumab 1 talimogene laherparepvec 1 sargramostim 1 relatlimab 1 regorafenib 1 prednylidene 1 poly ICLC 1 fludarabine phosphate 1 fludarabine 1 flt3 ligand protein 1 durvalumab 1 deltacortene 1 decitabine and cedazuridine drug combination 1 aflibercept 1 X-Rays 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡